Lind

Intelligent Research Platform for Health Systems

San Francisco · $5.5M raised

Headquarters
San Francisco
Business Model
B2B
Website
lind.care
Total Funding
$5.5M
Last Round
$5.5M SeedJan 2026
Rounds
1

About

Lind is an AI-powered clinical trial screening and matching platform built for health systems rather than pharmaceutical sponsors. The platform screens every patient against every open study nightly, using EHR-native data to surface matches with clinical evidence already mapped to eligibility criteria, helping trial coordinators identify candidates without adding to their workload. Founded by CEO Ognjen "Oggie" Nikolic (ex-Google, GRAIL) and CTO Pranav Singh (ex-Illumina, GRAIL, Upstart), Lind is based in San Francisco and raised a $5.5 million seed round in December 2023 led by 8VC, Abstract Ventures, and Correlation Ventures.

Summary

Lind is an Artificial Intelligence company based in San Francisco. It has raised $5.5M in total across 1 round, most recently a $5.5M Seed round in Jan 2026. Investors include 8VC, Abstract Ventures and Correlation Ventures.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJan 2026
$5.5M

Investors

Similar Companies